KINH_HUMAN - dbPTM
KINH_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID KINH_HUMAN
UniProt AC P33176
Protein Name Kinesin-1 heavy chain
Gene Name KIF5B
Organism Homo sapiens (Human).
Sequence Length 963
Subcellular Localization Cytoplasm, cytoskeleton . Uniformly distributed between soma and neurites in hippocampal neurons.
Protein Description Microtubule-dependent motor required for normal distribution of mitochondria and lysosomes. Can induce formation of neurite-like membrane protrusions in non-neuronal cells in a ZFYVE27-dependent manner (By similarity). Regulates centrosome and nuclear positioning during mitotic entry. During the G2 phase of the cell cycle in a BICD2-dependent manner, antagonizes dynein function and drives the separation of nuclei and centrosomes. [PubMed: 20386726]
Protein Sequence MADLAECNIKVMCRFRPLNESEVNRGDKYIAKFQGEDTVVIASKPYAFDRVFQSSTSQEQVYNDCAKKIVKDVLEGYNGTIFAYGQTSSGKTHTMEGKLHDPEGMGIIPRIVQDIFNYIYSMDENLEFHIKVSYFEIYLDKIRDLLDVSKTNLSVHEDKNRVPYVKGCTERFVCSPDEVMDTIDEGKSNRHVAVTNMNEHSSRSHSIFLINVKQENTQTEQKLSGKLYLVDLAGSEKVSKTGAEGAVLDEAKNINKSLSALGNVISALAEGSTYVPYRDSKMTRILQDSLGGNCRTTIVICCSPSSYNESETKSTLLFGQRAKTIKNTVCVNVELTAEQWKKKYEKEKEKNKILRNTIQWLENELNRWRNGETVPIDEQFDKEKANLEAFTVDKDITLTNDKPATAIGVIGNFTDAERRKCEEEIAKLYKQLDDKDEEINQQSQLVEKLKTQMLDQEELLASTRRDQDNMQAELNRLQAENDASKEEVKEVLQALEELAVNYDQKSQEVEDKTKEYELLSDELNQKSATLASIDAELQKLKEMTNHQKKRAAEMMASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVARLYISKMKSEVKTMVKRCKQLESTQTESNKKMEENEKELAACQLRISQHEAKIKSLTEYLQNVEQKKRQLEESVDALSEELVQLRAQEKVHEMEKEHLNKVQTANEVKQAVEQQIQSHRETHQKQISSLRDEVEAKAKLITDLQDQNQKMMLEQERLRVEHEKLKATDQEKSRKLHELTVMQDRREQARQDLKGLEETVAKELQTLHNLRKLFVQDLATRVKKSAEIDSDDTGGSAAQKQKISFLENNLEQLTKVHKQLVRDNADLRCELPKLEKRLRATAERVKALESALKEAKENASRDRKRYQQEVDRIKEAVRSKNMARRGHSAQIAKPIRPGQHPAASPTHPSAIRGGGAFVQNSQPVAVRGGGGKQV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MADLAECNI
------CCCHHHCCE
22.1122223895
10AcetylationDLAECNIKVMCRFRP
CHHHCCEEEEEEECC
15.2123749302
10MalonylationDLAECNIKVMCRFRP
CHHHCCEEEEEEECC
15.2126320211
10UbiquitinationDLAECNIKVMCRFRP
CHHHCCEEEEEEECC
15.21-
21PhosphorylationRFRPLNESEVNRGDK
EECCCCHHHCCCCCC
45.8524719451
28AcetylationSEVNRGDKYIAKFQG
HHCCCCCCEEEEECC
41.1819608861
38PhosphorylationAKFQGEDTVVIASKP
EEECCCCEEEEECCC
16.6328152594
43PhosphorylationEDTVVIASKPYAFDR
CCEEEEECCCCCHHH
24.0428152594
44AcetylationDTVVIASKPYAFDRV
CEEEEECCCCCHHHH
32.7825953088
44UbiquitinationDTVVIASKPYAFDRV
CEEEEECCCCCHHHH
32.78-
46PhosphorylationVVIASKPYAFDRVFQ
EEEECCCCCHHHHCC
24.5228152594
55PhosphorylationFDRVFQSSTSQEQVY
HHHHCCCCCCHHHHH
22.6921712546
65GlutathionylationQEQVYNDCAKKIVKD
HHHHHHHHHHHHHHH
5.4922555962
65S-nitrosylationQEQVYNDCAKKIVKD
HHHHHHHHHHHHHHH
5.492212679
67AcetylationQVYNDCAKKIVKDVL
HHHHHHHHHHHHHHH
49.7325953088
67UbiquitinationQVYNDCAKKIVKDVL
HHHHHHHHHHHHHHH
49.73-
95SulfoxidationSSGKTHTMEGKLHDP
CCCCEEEEECEECCC
5.0530846556
98AcetylationKTHTMEGKLHDPEGM
CEEEEECEECCCCCC
29.3725953088
105SulfoxidationKLHDPEGMGIIPRIV
EECCCCCCCCHHHHH
3.1221406390
149PhosphorylationIRDLLDVSKTNLSVH
HHHHHCHHCCCCCCC
33.1726552605
150UbiquitinationRDLLDVSKTNLSVHE
HHHHCHHCCCCCCCC
41.08-
151PhosphorylationDLLDVSKTNLSVHED
HHHCHHCCCCCCCCC
33.6126552605
154PhosphorylationDVSKTNLSVHEDKNR
CHHCCCCCCCCCCCC
24.4125849741
159UbiquitinationNLSVHEDKNRVPYVK
CCCCCCCCCCCCCCC
43.60-
164PhosphorylationEDKNRVPYVKGCTER
CCCCCCCCCCCCCCC
16.3730631047
166AcetylationKNRVPYVKGCTERFV
CCCCCCCCCCCCCEE
42.2819608861
166MalonylationKNRVPYVKGCTERFV
CCCCCCCCCCCCCEE
42.2826320211
174GlutathionylationGCTERFVCSPDEVMD
CCCCCEEECHHHHHH
4.4922555962
175PhosphorylationCTERFVCSPDEVMDT
CCCCEEECHHHHHHC
30.0428348404
195PhosphorylationSNRHVAVTNMNEHSS
CCCCEEEECCCCCCC
21.0022210691
197SulfoxidationRHVAVTNMNEHSSRS
CCEEEECCCCCCCCC
4.5530846556
201PhosphorylationVTNMNEHSSRSHSIF
EECCCCCCCCCCEEE
22.6721406692
202PhosphorylationTNMNEHSSRSHSIFL
ECCCCCCCCCCEEEE
39.4421406692
204PhosphorylationMNEHSSRSHSIFLIN
CCCCCCCCCEEEEEE
24.4323312004
206PhosphorylationEHSSRSHSIFLINVK
CCCCCCCEEEEEEEE
19.1123312004
213AcetylationSIFLINVKQENTQTE
EEEEEEEEECCCCCC
47.6226051181
213SumoylationSIFLINVKQENTQTE
EEEEEEEEECCCCCC
47.6228112733
222UbiquitinationENTQTEQKLSGKLYL
CCCCCCHHHCCEEEE
38.0921906983
224PhosphorylationTQTEQKLSGKLYLVD
CCCCHHHCCEEEEEE
40.7029391485
226UbiquitinationTEQKLSGKLYLVDLA
CCHHHCCEEEEEECC
30.49-
228PhosphorylationQKLSGKLYLVDLAGS
HHHCCEEEEEECCCC
14.2528152594
237MalonylationVDLAGSEKVSKTGAE
EECCCCCCCCCCCCC
54.2126320211
240UbiquitinationAGSEKVSKTGAEGAV
CCCCCCCCCCCCCCH
54.70-
252MalonylationGAVLDEAKNINKSLS
CCHHHHHHHHHHHHH
57.2026320211
252UbiquitinationGAVLDEAKNINKSLS
CCHHHHHHHHHHHHH
57.2021906983
256UbiquitinationDEAKNINKSLSALGN
HHHHHHHHHHHHHHH
49.31-
257PhosphorylationEAKNINKSLSALGNV
HHHHHHHHHHHHHHH
24.0628348404
259PhosphorylationKNINKSLSALGNVIS
HHHHHHHHHHHHHHH
28.6528348404
277PhosphorylationEGSTYVPYRDSKMTR
CCCCCCCCCCCHHHH
19.60-
294GlutathionylationQDSLGGNCRTTIVIC
HHHCCCCCEEEEEEE
4.6522555962
303PhosphorylationTTIVICCSPSSYNES
EEEEEEECCCCCCCC
24.3330576142
312PhosphorylationSSYNESETKSTLLFG
CCCCCCHHCCEEECC
39.3030576142
314PhosphorylationYNESETKSTLLFGQR
CCCCHHCCEEECCCC
31.5430576142
321MethylationSTLLFGQRAKTIKNT
CEEECCCCCCCCCCE
38.13115481283
346AcetylationQWKKKYEKEKEKNKI
HHHHHHHHHHHHHHH
71.626570053
382AcetylationPIDEQFDKEKANLEA
CCCHHCCHHHHCCEE
63.5023236377
382UbiquitinationPIDEQFDKEKANLEA
CCCHHCCHHHHCCEE
63.50-
384UbiquitinationDEQFDKEKANLEAFT
CHHCCHHHHCCEEEE
48.60-
394UbiquitinationLEAFTVDKDITLTND
CEEEEECCCCEECCC
46.85-
397PhosphorylationFTVDKDITLTNDKPA
EEECCCCEECCCCCC
37.3522199227
399PhosphorylationVDKDITLTNDKPATA
ECCCCEECCCCCCCE
32.4922199227
402UbiquitinationDITLTNDKPATAIGV
CCEECCCCCCCEEEE
38.33-
405O-linked_GlycosylationLTNDKPATAIGVIGN
ECCCCCCCEEEEEEC
27.6023301498
405PhosphorylationLTNDKPATAIGVIGN
ECCCCCCCEEEEEEC
27.6022199227
414PhosphorylationIGVIGNFTDAERRKC
EEEEECCCHHHHHHH
38.00-
420UbiquitinationFTDAERRKCEEEIAK
CCHHHHHHHHHHHHH
52.82-
427UbiquitinationKCEEEIAKLYKQLDD
HHHHHHHHHHHHHCC
58.99-
430AcetylationEEIAKLYKQLDDKDE
HHHHHHHHHHCCCCH
55.6226051181
430UbiquitinationEEIAKLYKQLDDKDE
HHHHHHHHHHCCCCH
55.62-
448UbiquitinationQQSQLVEKLKTQMLD
HHHHHHHHHHHHCCC
48.05-
451PhosphorylationQLVEKLKTQMLDQEE
HHHHHHHHHCCCHHH
29.6421406692
462PhosphorylationDQEELLASTRRDQDN
CHHHHHHHHHCCHHH
23.5524719451
463PhosphorylationQEELLASTRRDQDNM
HHHHHHHHHCCHHHH
24.9024719451
464DimethylationEELLASTRRDQDNMQ
HHHHHHHHCCHHHHH
37.37-
464MethylationEELLASTRRDQDNMQ
HHHHHHHHCCHHHHH
37.37115390193
470SulfoxidationTRRDQDNMQAELNRL
HHCCHHHHHHHHHHH
5.5621406390
505UbiquitinationLAVNYDQKSQEVEDK
HHCCCCCCCHHHHHH
51.73-
512AcetylationKSQEVEDKTKEYELL
CCHHHHHHHHHHHHH
48.2523749302
513PhosphorylationSQEVEDKTKEYELLS
CHHHHHHHHHHHHHH
41.2428796482
514UbiquitinationQEVEDKTKEYELLSD
HHHHHHHHHHHHHHH
65.13-
516PhosphorylationVEDKTKEYELLSDEL
HHHHHHHHHHHHHHH
17.2728796482
526UbiquitinationLSDELNQKSATLASI
HHHHHHHHHHHHHHH
40.77-
539UbiquitinationSIDAELQKLKEMTNH
HHHHHHHHHHHHCHH
74.32-
543SulfoxidationELQKLKEMTNHQKKR
HHHHHHHHCHHHHHH
4.3230846556
544PhosphorylationLQKLKEMTNHQKKRA
HHHHHHHCHHHHHHH
30.5528270605
549AcetylationEMTNHQKKRAAEMMA
HHCHHHHHHHHHHHH
40.477408757
557PhosphorylationRAAEMMASLLKDLAE
HHHHHHHHHHHHHHH
19.1524719451
560AcetylationEMMASLLKDLAEIGI
HHHHHHHHHHHHHCE
56.867408767
582SulfoxidationKQPEGTGMIDEEFTV
CCCCCCCCCCCCHHH
3.3330846556
593PhosphorylationEFTVARLYISKMKSE
CHHHHHHHHHHHHHH
9.5227107777
599PhosphorylationLYISKMKSEVKTMVK
HHHHHHHHHHHHHHH
44.0923836654
602AcetylationSKMKSEVKTMVKRCK
HHHHHHHHHHHHHHH
27.1825953088
609AcetylationKTMVKRCKQLESTQT
HHHHHHHHHHHHHCC
63.057619063
609UbiquitinationKTMVKRCKQLESTQT
HHHHHHHHHHHHHCC
63.05-
613PhosphorylationKRCKQLESTQTESNK
HHHHHHHHHCCHHHH
34.1124850871
614PhosphorylationRCKQLESTQTESNKK
HHHHHHHHCCHHHHH
30.0924850871
618PhosphorylationLESTQTESNKKMEEN
HHHHCCHHHHHHHHH
58.2924850871
622SulfoxidationQTESNKKMEENEKEL
CCHHHHHHHHHHHHH
9.2530846556
632GlutathionylationNEKELAACQLRISQH
HHHHHHHHHHHHHHH
3.0522555962
644UbiquitinationSQHEAKIKSLTEYLQ
HHHHHHHHHHHHHHH
38.41-
645PhosphorylationQHEAKIKSLTEYLQN
HHHHHHHHHHHHHHH
43.9528152594
647PhosphorylationEAKIKSLTEYLQNVE
HHHHHHHHHHHHHHH
29.6728152594
649PhosphorylationKIKSLTEYLQNVEQK
HHHHHHHHHHHHHHH
14.3528152594
656AcetylationYLQNVEQKKRQLEES
HHHHHHHHHHHHHHH
36.1025953088
656UbiquitinationYLQNVEQKKRQLEES
HHHHHHHHHHHHHHH
36.10-
657UbiquitinationLQNVEQKKRQLEESV
HHHHHHHHHHHHHHH
45.10-
663PhosphorylationKKRQLEESVDALSEE
HHHHHHHHHHHHHHH
18.87-
679UbiquitinationVQLRAQEKVHEMEKE
HHHHHHHHHHHHHHH
36.49-
683SulfoxidationAQEKVHEMEKEHLNK
HHHHHHHHHHHHHHH
5.5630846556
690UbiquitinationMEKEHLNKVQTANEV
HHHHHHHHHHHHHHH
41.92-
698UbiquitinationVQTANEVKQAVEQQI
HHHHHHHHHHHHHHH
26.76-
717PhosphorylationETHQKQISSLRDEVE
HHHHHHHHHHHHHHH
22.3324719451
718PhosphorylationTHQKQISSLRDEVEA
HHHHHHHHHHHHHHH
29.1125954137
728AcetylationDEVEAKAKLITDLQD
HHHHHHHHHHHHHHH
39.4525953088
761AcetylationLKATDQEKSRKLHEL
HHCCHHHHHHHHHHH
50.3420167786
764AcetylationTDQEKSRKLHELTVM
CHHHHHHHHHHHHHH
62.3820167786
764MalonylationTDQEKSRKLHELTVM
CHHHHHHHHHHHHHH
62.3826320211
764UbiquitinationTDQEKSRKLHELTVM
CHHHHHHHHHHHHHH
62.38-
771SulfoxidationKLHELTVMQDRREQA
HHHHHHHHHHHHHHH
2.6421406390
783AcetylationEQARQDLKGLEETVA
HHHHHHHHHHHHHHH
70.5125953088
783UbiquitinationEQARQDLKGLEETVA
HHHHHHHHHHHHHHH
70.512190698
791UbiquitinationGLEETVAKELQTLHN
HHHHHHHHHHHHHHH
55.40-
795PhosphorylationTVAKELQTLHNLRKL
HHHHHHHHHHHHHHH
42.4821082442
801MalonylationQTLHNLRKLFVQDLA
HHHHHHHHHHHHHHH
49.8226320211
801UbiquitinationQTLHNLRKLFVQDLA
HHHHHHHHHHHHHHH
49.82-
814PhosphorylationLATRVKKSAEIDSDD
HHHHHHHHHCCCCCC
25.9729396449
819PhosphorylationKKSAEIDSDDTGGSA
HHHHCCCCCCCCCCH
42.9425159151
822PhosphorylationAEIDSDDTGGSAAQK
HCCCCCCCCCCHHHH
48.7328985074
825PhosphorylationDSDDTGGSAAQKQKI
CCCCCCCCHHHHHHH
23.0621815630
829UbiquitinationTGGSAAQKQKISFLE
CCCCHHHHHHHHHHH
49.16-
833PhosphorylationAAQKQKISFLENNLE
HHHHHHHHHHHHCHH
30.7125159151
844UbiquitinationNNLEQLTKVHKQLVR
HCHHHHHHHHHHHHH
51.43-
847UbiquitinationEQLTKVHKQLVRDNA
HHHHHHHHHHHHCCC
48.60-
885UbiquitinationESALKEAKENASRDR
HHHHHHHHHHHHHHH
53.22-
901MethylationRYQQEVDRIKEAVRS
HHHHHHHHHHHHHHH
47.24-
917PhosphorylationNMARRGHSAQIAKPI
CHHHCCCCCCCCCCC
25.3720068231
922AcetylationGHSAQIAKPIRPGQH
CCCCCCCCCCCCCCC
42.4826051181
922UbiquitinationGHSAQIAKPIRPGQH
CCCCCCCCCCCCCCC
42.48-
933PhosphorylationPGQHPAASPTHPSAI
CCCCCCCCCCCCCCC
32.2229255136
935PhosphorylationQHPAASPTHPSAIRG
CCCCCCCCCCCCCCC
43.8829255136
938PhosphorylationAASPTHPSAIRGGGA
CCCCCCCCCCCCCCC
28.8229255136
950O-linked_GlycosylationGGAFVQNSQPVAVRG
CCCCCCCCCCEEECC
20.8323301498
950PhosphorylationGGAFVQNSQPVAVRG
CCCCCCCCCCEEECC
20.8328857561
956MethylationNSQPVAVRGGGGKQV
CCCCEEECCCCCCCC
28.4424129315

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of KINH_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of KINH_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of KINH_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SNP23_HUMANSNAP23physical
12475239
SNP25_HUMANSNAP25physical
12475239
KLC1_HUMANKLC1physical
12475239
1433F_HUMANYWHAHphysical
11969417
KLC2_HUMANKLC2physical
22939629
KLC1_HUMANKLC1physical
22939629
KLC4_HUMANKLC4physical
22939629
ZBT8B_HUMANZBTB8Bphysical
22939629
MCCA_HUMANMCCC1physical
22939629
TWF1_HUMANTWF1physical
22939629
SRP68_HUMANSRP68physical
22939629
RN168_HUMANRNF168physical
22939629
ACACA_HUMANACACAphysical
22863883
ICAL_HUMANCASTphysical
22863883
COPE_HUMANCOPEphysical
22863883
CSN5_HUMANCOPS5physical
22863883
PSA2_HUMANPSMA2physical
22863883
PSA4_HUMANPSMA4physical
22863883
PSA5_HUMANPSMA5physical
22863883
PSB3_HUMANPSMB3physical
22863883
PSB4_HUMANPSMB4physical
22863883
PSB5_HUMANPSMB5physical
22863883
PSB6_HUMANPSMB6physical
22863883
PSB7_HUMANPSMB7physical
22863883
PSME1_HUMANPSME1physical
22863883
PTN23_HUMANPTPN23physical
22863883
RBGP1_HUMANRABGAP1physical
22863883
P4R3B_HUMANSMEK2physical
22863883
KAP3_HUMANPRKAR2Bphysical
25416956
VPS52_HUMANVPS52physical
25416956
TAXB1_HUMANTAX1BP1physical
25416956
ZBT8A_HUMANZBTB8Aphysical
25416956
LSM2_HUMANLSM2physical
26344197
KLC1_HUMANKLC1physical
26496610
NHS_HUMANNHSphysical
26496610
PIT1_HUMANPOU1F1physical
26496610
TBA1A_HUMANTUBA1Aphysical
26496610
OGT1_HUMANOGTphysical
26496610
SQSTM_HUMANSQSTM1physical
26496610
XPR1_HUMANXPR1physical
26496610
NCOR1_HUMANNCOR1physical
26496610
TRAK1_HUMANTRAK1physical
26496610
KDIS_HUMANKIDINS220physical
26496610
KLC2_HUMANKLC2physical
26496610
KLC4_HUMANKLC4physical
26496610
S38AA_HUMANSLC38A10physical
26496610
KLC3_HUMANKLC3physical
26496610
OSTM1_MOUSEOstm1physical
26598607

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of KINH_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-933, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-166, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-933, AND MASS SPECTROMETRY.

TOP